Compounded Tirzepatide vs Mounjaro: What You Need to Know
Quick answer
Mounjaro and compounded tirzepatide contain the same active molecule. Mounjaro is Eli Lilly's brand-name product approved for type 2 diabetes (and used off-label for weight loss). Compounded tirzepatide is made by licensed US pharmacies at roughly 80% less cost. The clinical compound is identical.
Side-by-side comparison
| Compounded Tirzepatide | Mounjaro (brand-name tirzepatide) | |
|---|---|---|
| Active compound | Tirzepatide | Tirzepatide |
| FDA-approved indication | Pharmacy-compounded (not product-approved) | Type 2 diabetes (off-label for weight loss) |
| Manufacturer | Licensed US compounding pharmacy | Eli Lilly |
| Monthly cost | From $197/mo | ~$1,023/mo retail |
| Dose options | Custom dosing per provider | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
| Delivery format | Pre-dosed pens | Pre-filled single-dose pens |
| Includes consultation | Yes -- included in price | Separate doctor visit required |
| Shipping | Direct monthly delivery | Pharmacy pickup or mail-order |
Compounded Tirzepatide
Compounded tirzepatide from LYV is prepared by licensed US compounding pharmacies and delivered in pre-dosed pens. The active molecule is identical to Mounjaro. Your prescribing provider determines the dose based on your goals and response. Every lot is batch-tested. The key advantage is cost -- roughly $197/mo compared to $1,000+ for brand-name -- plus the flexibility to customize dosing beyond Eli Lilly's fixed pen sizes.
Mounjaro (brand-name tirzepatide)
Mounjaro is Eli Lilly's brand-name tirzepatide, FDA-approved for type 2 diabetes in May 2022. It is widely prescribed off-label for weight loss based on the SURMOUNT trial data. Mounjaro comes in pre-filled pens at six dose levels (2.5mg through 15mg). The retail price is approximately $1,023/month without insurance. Eli Lilly offers a savings card that can reduce costs for commercially insured patients, but availability and terms change frequently.
Key differences
- •Same molecule, different regulatory pathway. Mounjaro is an FDA-approved product; compounded tirzepatide is prepared by FDA-regulated pharmacies.
- •Mounjaro's approved indication is type 2 diabetes. It is prescribed off-label for weight loss. Zepbound (same molecule) has the weight management indication.
- •Compounded tirzepatide costs roughly 80% less -- a meaningful difference when treatment is ongoing.
- •LYV's compounded version includes the provider consultation, prescription, and shipping in one price. Mounjaro requires a separate doctor visit and pharmacy trip.
- •Compounding allows dose customization. Some patients benefit from doses between Eli Lilly's fixed increments.
Which should you choose?
Compounded Tirzepatide
Choose compounded tirzepatide if you want the same active compound at a fraction of the cost with the convenience of an all-in-one subscription. Most people paying out of pocket will save $800+/mo.
Mounjaro (brand-name tirzepatide)
Choose Mounjaro if your insurance covers it with a low copay, or if you specifically need an FDA-approved product for a type 2 diabetes indication. If your out-of-pocket cost is similar, brand-name is a fine option.
Frequently asked questions
Is Mounjaro the same thing as tirzepatide?
Yes. Mounjaro is the brand name. Tirzepatide is the active compound. They are the same molecule. Eli Lilly also sells tirzepatide under the brand name Zepbound for weight management.
Can I use compounded tirzepatide for diabetes?
Your prescribing provider determines the appropriate use based on your medical history. Tirzepatide is clinically proven for both type 2 diabetes (Mounjaro indication) and weight management (Zepbound indication). The compound works the same regardless of the source.
Is the dosing the same?
Compounded tirzepatide can be dosed at the same levels as Mounjaro. The advantage of compounding is flexibility -- your provider can prescribe exact doses that may fall between Eli Lilly's fixed pen sizes if that better suits your titration schedule.
How do I know the compounding pharmacy is legitimate?
LYV partners with US-based compounding pharmacies licensed by their state board of pharmacy and registered with the FDA. These pharmacies follow current Good Manufacturing Practices and batch-test every production lot. You can verify any pharmacy's license through your state board.
What if brand-name tirzepatide becomes affordable?
If Eli Lilly reduces pricing or insurance coverage improves to the point where Mounjaro or Zepbound costs less than compounded tirzepatide, that would be a reasonable switch. The clinical compound is identical either way. LYV exists to make effective treatments accessible at fair prices.
Ready to see which option fits your goals?
Take a 2-minute quiz. Get a personalized protocol.